CRISPR Therapeutics
Gene-based medicine development
- B2B
About CRISPR Therapeutics
A leading gene editing company developing gene-based medicines for serious diseases, using CRISPR/Cas9 technology and collaborating with industry leaders
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- boston, massachusetts, United States
- Founded
- 2013
- Revenue
- $3.5MFY2025, publicly reported
- Website
- crisprtx.com
CRISPR Therapeutics at a glance
CRISPR Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.
CRISPR Therapeutics was founded in 2013.
CRISPR Therapeutics has 251–1,000 employees.
CRISPR Therapeutics's revenue is $3.5M (FY2025, publicly reported).
Frequently asked questions about CRISPR Therapeutics
What is CRISPR Therapeutics's revenue?
CRISPR Therapeutics's revenue is $3.5M (FY2025, publicly reported).
How many employees does CRISPR Therapeutics have?
CRISPR Therapeutics has 251–1,000 employees.
Where is CRISPR Therapeutics headquartered?
CRISPR Therapeutics is headquartered in boston, massachusetts, United States.
Selling to companies like CRISPR Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies